1. Home
  2. PRTA vs DAKT Comparison

PRTA vs DAKT Comparison

Compare PRTA & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • DAKT
  • Stock Information
  • Founded
  • PRTA 2012
  • DAKT 1968
  • Country
  • PRTA Ireland
  • DAKT United States
  • Employees
  • PRTA N/A
  • DAKT N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • DAKT Office Equipment/Supplies/Services
  • Sector
  • PRTA Health Care
  • DAKT Industrials
  • Exchange
  • PRTA Nasdaq
  • DAKT Nasdaq
  • Market Cap
  • PRTA 809.8M
  • DAKT 789.7M
  • IPO Year
  • PRTA N/A
  • DAKT 1994
  • Fundamental
  • Price
  • PRTA $15.27
  • DAKT $12.70
  • Analyst Decision
  • PRTA Buy
  • DAKT Strong Buy
  • Analyst Count
  • PRTA 9
  • DAKT 1
  • Target Price
  • PRTA $54.57
  • DAKT $26.00
  • AVG Volume (30 Days)
  • PRTA 396.4K
  • DAKT 503.7K
  • Earning Date
  • PRTA 05-07-2025
  • DAKT 03-05-2025
  • Dividend Yield
  • PRTA N/A
  • DAKT N/A
  • EPS Growth
  • PRTA N/A
  • DAKT N/A
  • EPS
  • PRTA N/A
  • DAKT 0.04
  • Revenue
  • PRTA $135,157,000.00
  • DAKT $799,806,000.00
  • Revenue This Year
  • PRTA N/A
  • DAKT $0.81
  • Revenue Next Year
  • PRTA $106.71
  • DAKT $4.73
  • P/E Ratio
  • PRTA N/A
  • DAKT $347.77
  • Revenue Growth
  • PRTA 47.92
  • DAKT N/A
  • 52 Week Low
  • PRTA $11.70
  • DAKT $8.69
  • 52 Week High
  • PRTA $30.86
  • DAKT $19.89
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 54.26
  • DAKT 27.14
  • Support Level
  • PRTA $13.89
  • DAKT $10.24
  • Resistance Level
  • PRTA $16.16
  • DAKT $13.29
  • Average True Range (ATR)
  • PRTA 1.14
  • DAKT 0.77
  • MACD
  • PRTA 0.04
  • DAKT -0.35
  • Stochastic Oscillator
  • PRTA 53.11
  • DAKT 37.79

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: